Roche Extends Illumina Bid Again - Analyst Blog

By
A A A

Not even a month and Roche Holdings Ltd. ( RHHBY ) announced the extension of its Illumina, Inc. ( ILMN ) bid for the second time. Roche recently announced that it has extended the time period for acquiring all outstanding shares of Illumina to April 20, 2012, from the previously-announced date (March 23, 2012). Roche also said that apart from the extension of the tender offer expiration date, all other terms and conditions remain unchanged.

On the 27 th of last month, Roche had extended the time-frame to March 23 from February 24, 2012. Roche had first announced its bid in January to acquire all shares of Illumina at an offer price of $44.50 per share (aggregate value $5.7 billion) in cash.

In mid-March 2012, the Federal Trade Commission ( FTC ) requested additional information regarding the proposed acquisition of Illumina. The request, termed a 'second request,' sought additional information about Roche's microarray business.


The second request extended the waiting period, imposed by the Hart-Scott-Rodino Antitrust Improvements Act, by 10 days after Roche complies with the request. The extension can be increased voluntarily by Roche or terminated sooner by the FTC.

Post the potential acquisition, Roche intends to combine Illumina with its Applied Science business, thereby strengthening its current offerings in the Life Science market. Roche operates through two segments - Pharmaceuticals and Diagnostics. Applied Science is a wing under the company's Diagnostics division.

Roche believes that this acquisition will strengthen its position in the sequencing and microarrays market. Moreover, it will help address the growing demand for genetic/genomic solutions.

We currently have a Zacks #3 Rank (short-term Hold rating) on Roche. We believe that this transaction will add to the company's portfolio, thereby driving long-term growth.


 
ILLUMINA INC ( ILMN ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: FTC , ILMN

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

41,357,260
  • $17.6028 ▲ 0.42%
32,495,005
  • $112.33 ▼ 0.28%
28,948,210
  • $25.231 ▲ 0.36%
27,384,739
  • $47.86 ▲ 0.72%
24,409,419
  • $6.98 ▲ 5.12%
23,855,728
  • $27.6928 ▲ 0.15%
23,839,021
  • $36.40 ▼ 1.67%
21,416,985
  • $9.54 ▼ 5.26%
As of 12/19/2014, 11:38 AM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com